Multiple Sclerosis

Researchers evaluated the value of neurofilament light chain levels as a cerebrospinal fluid or blood biomarker in patients with MS.

Researchers have discovered a new subtype of MS, providing a better understanding of the nature of the disease.

Researchers have discovered a new subtype of MS, providing a better understanding of the nature of the disease.

Discontinuing disease-modifying therapies is common among patients with MS but can increase the risk of progression or relapse.

Discontinuing disease-modifying therapies is common among patients with MS but can increase the risk of progression or relapse.

The US Food and Drug Administration has granted approval to a new dose of a drug used to treat relapsing forms of multiple sclerosis.

In a recent study, researchers investigated the effects of high levels of fat and vegetable intake on MS relapse rates in children.

The FDA has approved a generic option for the treatment of patients with relapsing forms of multiple sclerosis. For details, including dosage and common adverse effects, read more.

In a recent study, researchers investigated the effects of chronic comorbidities on time to diagnosis and mortality in patients with multiple sclerosis. For details, including which types of comorbidity...

In a recent study, researchers sought to determine whether and to what extent low vitamin D levels are associated with the risk for developing multiple sclerosis.